Morgan Stanley
RAPP

Morgan Stanley’s Rapport Therapeutics RAPP Stock Holding History

Morgan Stanley’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.19M Sell
165,954
-44,377
-21% -$1.25M ﹤0.01% 4105
2025
Q4 		$6.38M Sell
210,331
-64,237
-23% -$1.78M ﹤0.01% 3996
2025
Q3 		$8.15M Buy
274,568
+205,105
+295% +$3.66M ﹤0.01% 3720
2025
Q2 		$790K Sell
69,463
-7,141
-9% -$75.8K ﹤0.01% 5229
2025
Q1 		$768K Buy
76,604
+53,968
+238% +$701K ﹤0.01% 5124
2024
Q4 		$402K Sell
22,636
-1,592
-7% -$35.3K ﹤0.01% 5510
2024
Q3 		$496K Buy
+24,228
New +$521K ﹤0.01% 5412

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return